(Q40098498)

17 September 2017

title

Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice (English)

1 reference

17 September 2017

7

Xiaoyuan Chen

1 reference

17 September 2017

Weibo Cai

1

1 reference

17 September 2017

Alireza Ebrahimnejad

2

1 reference

17 September 2017

Kai Chen

3

1 reference

17 September 2017

Qizhen Cao

4

1 reference

17 September 2017

Zi-Bo Li

5

1 reference

17 September 2017

David A Tice

6

1 reference

17 September 2017

publication date

3 August 2007

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

17 September 2017

published in

1 reference

17 September 2017

volume

34

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

2024-2036

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0503-5

17 September 2017

exact match

0 references

cites work

Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso

1 reference

12 December 2020

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

1 reference

12 December 2020

The ephrins and Eph receptors in angiogenesis

1 reference

12 December 2020

Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior

1 reference

12 December 2020

EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

1 reference

12 December 2020

Eph receptor tyrosine kinases in tumor and tumor microenvironment

1 reference

12 December 2020

Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor

1 reference

12 December 2020

In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.

1 reference

12 December 2020

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

1 reference

12 December 2020

Dosimetry of internal emitters

1 reference

12 December 2020

Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth

1 reference

12 December 2020

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

1 reference

12 December 2020

A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression

1 reference

12 December 2020

Inhibition of retinal neovascularization by soluble EphA2 receptor

1 reference

12 December 2020

Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties

1 reference

12 December 2020

PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.

1 reference

12 December 2020

EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.

1 reference

12 December 2020

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

1 reference

12 December 2020

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

1 reference

12 December 2020

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

1 reference

12 December 2020

Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist

1 reference

12 December 2020

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

1 reference

12 December 2020

Cell adhesion molecule CEACAM1 associates with paxillin in granulocytes and epithelial and endothelial cells

1 reference

12 December 2020

An ephrin mimetic peptide that selectively targets the EphA2 receptor

1 reference

12 December 2020

EphA2 expression is associated with aggressive features in ovarian carcinoma

1 reference

12 December 2020

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

1 reference

12 December 2020

Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis

1 reference

12 December 2020

Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin

1 reference

12 December 2020

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

1 reference

12 December 2020

How molecular imaging is speeding up antiangiogenic drug development

1 reference

12 December 2020

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

1 reference

12 December 2020

Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.

1 reference

12 December 2020

Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.

1 reference

12 December 2020

PET of vascular endothelial growth factor receptor expression.

1 reference

12 December 2020

Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer

1 reference

12 December 2020

Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody

1 reference

12 December 2020

In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice

1 reference

12 December 2020

Copper-64-labeled antibodies for PET imaging

1 reference

12 December 2020

Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions

1 reference

12 December 2020

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

1 reference

12 December 2020

Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells.

1 reference

12 December 2020

10.1007/S00259-007-0503-5

Identifiers

DOI

1 reference

17 September 2017

1 reference